Drug Manufacturers
Endo International PLC (NASDAQ:$ENDP) made the decision to lower its 2017 revenue forecast on Tuesday, August 8. The Malvern, Pennsylvania-based company said that it expects lower sales of branded drugs to add to the pricing ... [Read]